↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Johansson Edvin) "

Sökning: WFRF:(Johansson Edvin)

Resultat 1-10 av 56

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
1.	Hockings, Paul, 1956, et al. (författare) BIVARIATE MR IMAGING BIOMARKER TO IMPROVE PREDICTION OF ADVANCED FIBROSIS IN SUBJECTS WITH BIOPSY PROVEN NAFLD 2020 Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract Abstract not available
2.	Kero, Tanja, et al. (författare) Evaluation of quantitative CMR perfusion imaging by comparison with simultaneous 15O-water-PET 2021 Ingår i: Journal of Nuclear Cardiology. - : Springer Science and Business Media LLC. - 1071-3581 .- 1532-6551. ; 28, s. 1252-1266 Tidskriftsartikel (refereegranskat)abstract BackgroundWe assessed the quantitative accuracy of cardiac perfusion measurements using dynamic contrast-enhanced MRI with simultaneous 15O-water PET as reference with a fully integrated PET-MR scanner.Methods15 patients underwent simultaneous DCE MRI and 15O-water PET scans at rest and adenosine-stress on an integrated PET-MR scanner. Correlation and agreement between MRI- and PET-based global and regional MBF values were assessed using correlation and Bland–Altman analysis.ResultsThree subjects were excluded due to technical problems. Global mean (± SD) MBF values at rest and stress were 0.97 ± 0.27 and 3.19 ± 0.70 mL/g/min for MRI and 1.02 ± 0.28 and 3.13 ± 1.16 mL/g/min for PET (P = 0.66 and P = 0.81). The correlations between global and regional MRI- and PET-based MBF values were strong (r = 0.86 and r = 0.75). The biases were negligible for both global and regional MBF comparisons (0.01 and 0.00 mL/min/g for both), but the limits of agreement were wide for both global and regional MBF, with larger variability for high MBF-values.ConclusionThe correlation between simultaneous MBF measurements with DCE MRI and 15O-water PET measured in an integrated PET-MRI was strong but the agreement was only moderate indicating that MRI-based quantitative MBF measurements is not ready for clinical introduction.
3.	Parker, Victoria E. R., et al. (författare) Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes 2023 Ingår i: Nature Metabolism. - : NATURE PORTFOLIO. - 2522-5812. ; 5, s. 2086-2093 Tidskriftsartikel (refereegranskat)abstract Cotadutide is a dual glucagon-like peptide 1 and glucagon receptor agonist under development for the treatment of non-alcoholic steatohepatitis and type 2 diabetes mellitus (T2DM) and chronic kidney disease. Non-alcoholic steatohepatitis is a complex disease with no approved pharmacotherapies, arising from an underlying state of systemic metabolic dysfunction in association with T2DM and obesity. Cotadutide has been shown to improve glycaemic control, body weight, lipids, liver fat, inflammation and fibrosis. We conducted a two-part, randomized phase 2a trial in men and women with overweight or obesity diagnosed with T2DM to evaluate the efficacy and safety of cotadutide compared with placebo and liraglutide. The primary endpoints were change from baseline to day 28 of treatment in postprandial hepatic glycogen (part A) and to day 35 of treatment in fasting hepatic glycogen (part B) with cotadutide versus placebo. Secondary endpoints in part B were changes in fasting hepatic glycogen with cotadutide versus the mono glucagon-like peptide 1 receptor agonist, liraglutide, and change in hepatic fat fraction. The trial met its primary endpoint. We showed that cotadutide promotes greater reductions in liver glycogen and fat compared with placebo and liraglutide. Safety and tolerability findings with cotadutide were comparable to those of previous reports. Thus, this work provides evidence of additional benefits of cotadutide that could be attributed to glucagon receptor engagement. Our results suggest that cotadutide acts on the glucagon receptor in the human liver to promote glycogenolysis and improve the metabolic health of the liver. ClinicalTrials.gov registration: NCT03555994. In a two-part randomized phase 2a trial in men and women with overweight or obesity and type 2 diabetes mellitus, cotadutide promoted greater reductions in liver glycogen and fat than placebo and liraglutide.
4.	Vessby, Johan, et al. (författare) Non-Invasive Imaging Biomarkers to Detect Nash in Subjects with NAFLD 2020 Konferensbidrag (övrigt vetenskapligt/konstnärligt)
5.	Aad, G, et al. (författare) ATLAS Run 1 searches for direct pair production of third-generation squarks at the Large Hadron Collider. 2015 Ingår i: European Physical Journal C. Particles and Fields. - : Springer Science and Business Media LLC. - 1434-6044 .- 1434-6052. ; 75:10 Tidskriftsartikel (refereegranskat)
6.	Aad, G., et al. (författare) Constraints on new phenomena via Higgs boson couplings and invisible decays with the ATLAS detector 2015 Ingår i: Journal of High Energy Physics. - : Springer. - 1029-8479 .- 1126-6708. ; :11 Tidskriftsartikel (refereegranskat)
7.	Aad, G, et al. (författare) Determination of the Ratio of b-Quark Fragmentation Fractions f_{s}/f_{d} in pp Collisions at sqrt[s]=7 TeV with the ATLAS Detector. 2015 Ingår i: Physical Review Letters. - : American Physical Society. - 1079-7114 .- 0031-9007. ; 115:26 Tidskriftsartikel (refereegranskat)
8.	Aad, G., et al. (författare) Measurement of colour flow with the jet pull angle in t(t)over-bar events using the ATLAS detector at root s=8 TeV 2015 Tidskriftsartikel (refereegranskat)
9.	Aad, G., et al. (författare) Modelling Z -> tau tau processes in ATLAS with tau-embedded Z -> mu mu data 2015 Ingår i: Journal of Instrumentation. - : Elsevier. - 1748-0221. ; 10 Tidskriftsartikel (refereegranskat)
10.	Aad, G., et al. (författare) Search for an additional, heavy Higgs boson in the decay channel at in collision data with the ATLAS detector 2016 Ingår i: The European Physical Journal C. - : Springer Science and Business Media LLC. - 1434-6052. ; 76:1 Tidskriftsartikel (refereegranskat)

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 1-10 av 56

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (50); konferensbidrag (3); annan publikation (1); doktorsavhandling (1); forskningsöversikt (1)

Typ av innehåll: refereegranskat (52); övrigt vetenskapligt/konstnärligt (4)

Författare/redaktör: Chen, L (22); Aad, G (22); Abbott, B. (22); Abdallah, J (22); Abdinov, O (22); Lund-Jensen, Bengt (22); visa fler...; Strandberg, Jonas (22); Zwalinski, L. (22); Pöttgen, Ruth (22); Gregersen, K. (22); Kalderon, C.W. (22); Mullier, G.A. (22); Poettgen, R. (22); Aben, R. (22); Abramowicz, H. (22); Abreu, H. (22); Abreu, R. (22); Adye, T. (22); Agatonovic-Jovin, T. (22); Ahmadov, F. (22); Aielli, G. (22); Akimov, A. V. (22); Alberghi, G. L. (22); Albert, J. (22); Albrand, S. (22); Aleksa, M. (22); Aleksandrov, I. N. (22); Alexander, G. (22); Alexopoulos, T. (22); Alhroob, M. (22); Alimonti, G. (22); Alio, L. (22); Alison, J. (22); Allport, P. P. (22); Aloisio, A. (22); Alonso, A. (22); Alonso, F. (22); Alpigiani, C. (22); Altheimer, A. (22); Amako, K. (22); Amelung, C. (22); Amidei, D. (22); Amorim, A. (22); Amoroso, S. (22); Amram, N. (22); Amundsen, G. (22); Anastopoulos, C. (22); Ancu, L. S. (22); Andari, N. (22); Andeen, T. (22); visa färre...

Lärosäte: Lunds universitet (39); Uppsala universitet (24); Kungliga Tekniska Högskolan (22); Stockholms universitet (22); Umeå universitet (9); Chalmers tekniska högskola (5); visa fler...; Linköpings universitet (2); Sveriges Lantbruksuniversitet (2); Göteborgs universitet (1); Karolinska Institutet (1); visa färre...

Språk: Engelska (56)

Forskningsämne (UKÄ/SCB): Naturvetenskap (31); Medicin och hälsovetenskap (24); Teknik (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy